| Jay Todd Nilson, MD | |
|
10150 Centennial Pkwy Ste 230, Sandy, UT 84070-4123 | |
| (800) 594-5736 | |
| Not Available |
| Full Name | Jay Todd Nilson |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 32 Years |
| Location | 10150 Centennial Pkwy Ste 230, Sandy, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275639122 | NPI | - | NPPES |
| 7151 | Other | UT | HEALTHY U |
| 425650 | Other | UT | DESERET MUTUAL |
| PRA02246 | Other | UT | MOLINA |
| 107008628103 | Other | UT | IHC |
| 66104 | Other | UT | PEHP |
| QM0000054865 | Other | UT | ALTIUS |
| 870666269JTN | Other | UT | EDUCATORS MUTUAL |
| 190683600 | Other | UT | US DEPT OF LABOR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | G-83928 (California) | Secondary |
| 207L00000X | Anesthesiology | 366647-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| American Fork Hospital | American fork, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nph Anesthesia Of Utah Llc | 9537584313 | 96 |
News Archive
Obese women with large bellies may be at risk of developing a different subtype of breast cancer than those with widespread fat accumulation, according to a new study published in The Oncologist. This suggests that the link between breast cancer and obesity may be more complex than previously thought.
Metabolism encompasses the biochemical reactions that sustain life and is usually thought of as two complementary systems: one that breaks down nutrients to generate energy and another that harnesses this energy to produce the building blocks cells need to thrive.
Queen's University Belfast researchers at the Centre for Cancer Research and Cell Biology alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council award to develop a new antibody drug for the treatment of pancreatic cancer.
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
Quickly responding to international demand due to Japan's disabled nuclear power reactors, James W. Forsythe, M.D., H.M.D., has issued an "Emergency Radiation Medical Handbook" for use worldwide.
› Verified 1 days ago
| Entity Name | Lone Peak Anesthesia Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083622641 PECOS PAC ID: 9436057346 Enrollment ID: O20031229000973 |
News Archive
Obese women with large bellies may be at risk of developing a different subtype of breast cancer than those with widespread fat accumulation, according to a new study published in The Oncologist. This suggests that the link between breast cancer and obesity may be more complex than previously thought.
Metabolism encompasses the biochemical reactions that sustain life and is usually thought of as two complementary systems: one that breaks down nutrients to generate energy and another that harnesses this energy to produce the building blocks cells need to thrive.
Queen's University Belfast researchers at the Centre for Cancer Research and Cell Biology alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council award to develop a new antibody drug for the treatment of pancreatic cancer.
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
Quickly responding to international demand due to Japan's disabled nuclear power reactors, James W. Forsythe, M.D., H.M.D., has issued an "Emergency Radiation Medical Handbook" for use worldwide.
› Verified 1 days ago
| Entity Name | Rocky Mountain Anesthesiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487683215 PECOS PAC ID: 6305809492 Enrollment ID: O20041109001170 |
News Archive
Obese women with large bellies may be at risk of developing a different subtype of breast cancer than those with widespread fat accumulation, according to a new study published in The Oncologist. This suggests that the link between breast cancer and obesity may be more complex than previously thought.
Metabolism encompasses the biochemical reactions that sustain life and is usually thought of as two complementary systems: one that breaks down nutrients to generate energy and another that harnesses this energy to produce the building blocks cells need to thrive.
Queen's University Belfast researchers at the Centre for Cancer Research and Cell Biology alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council award to develop a new antibody drug for the treatment of pancreatic cancer.
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
Quickly responding to international demand due to Japan's disabled nuclear power reactors, James W. Forsythe, M.D., H.M.D., has issued an "Emergency Radiation Medical Handbook" for use worldwide.
› Verified 1 days ago
| Entity Name | North Valley Anesthesia, Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780908152 PECOS PAC ID: 9133315252 Enrollment ID: O20101201000020 |
News Archive
Obese women with large bellies may be at risk of developing a different subtype of breast cancer than those with widespread fat accumulation, according to a new study published in The Oncologist. This suggests that the link between breast cancer and obesity may be more complex than previously thought.
Metabolism encompasses the biochemical reactions that sustain life and is usually thought of as two complementary systems: one that breaks down nutrients to generate energy and another that harnesses this energy to produce the building blocks cells need to thrive.
Queen's University Belfast researchers at the Centre for Cancer Research and Cell Biology alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council award to develop a new antibody drug for the treatment of pancreatic cancer.
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
Quickly responding to international demand due to Japan's disabled nuclear power reactors, James W. Forsythe, M.D., H.M.D., has issued an "Emergency Radiation Medical Handbook" for use worldwide.
› Verified 1 days ago
| Entity Name | Nph Anesthesia Of Utah Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366077273 PECOS PAC ID: 9537584313 Enrollment ID: O20200811001268 |
News Archive
Obese women with large bellies may be at risk of developing a different subtype of breast cancer than those with widespread fat accumulation, according to a new study published in The Oncologist. This suggests that the link between breast cancer and obesity may be more complex than previously thought.
Metabolism encompasses the biochemical reactions that sustain life and is usually thought of as two complementary systems: one that breaks down nutrients to generate energy and another that harnesses this energy to produce the building blocks cells need to thrive.
Queen's University Belfast researchers at the Centre for Cancer Research and Cell Biology alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council award to develop a new antibody drug for the treatment of pancreatic cancer.
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
Quickly responding to international demand due to Japan's disabled nuclear power reactors, James W. Forsythe, M.D., H.M.D., has issued an "Emergency Radiation Medical Handbook" for use worldwide.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay Todd Nilson, MD 10150 Centennial Pkwy Ste 230, Sandy, UT 84070-4123 Ph: (800) 594-5736 | Jay Todd Nilson, MD 10150 Centennial Pkwy Ste 230, Sandy, UT 84070-4123 Ph: (800) 594-5736 |
News Archive
Obese women with large bellies may be at risk of developing a different subtype of breast cancer than those with widespread fat accumulation, according to a new study published in The Oncologist. This suggests that the link between breast cancer and obesity may be more complex than previously thought.
Metabolism encompasses the biochemical reactions that sustain life and is usually thought of as two complementary systems: one that breaks down nutrients to generate energy and another that harnesses this energy to produce the building blocks cells need to thrive.
Queen's University Belfast researchers at the Centre for Cancer Research and Cell Biology alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council award to develop a new antibody drug for the treatment of pancreatic cancer.
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
Quickly responding to international demand due to Japan's disabled nuclear power reactors, James W. Forsythe, M.D., H.M.D., has issued an "Emergency Radiation Medical Handbook" for use worldwide.
› Verified 1 days ago
Ralph Ernest Hannah, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9660 S 1300e, Sandy, UT 84094 Phone: 801-993-9582 Fax: 801-733-5618 | |
Mr. Clinton Lund Christensen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 9660 South 1300 East, Alta View Hospital, Sandy, UT 84094 Phone: 801-501-2600 | |
Todd S Blood, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 9660 South 1300 East, Alta View Hospital, Sandy, UT 84094 Phone: 801-501-2600 Fax: 801-733-5618 | |
Dr. Natalia Alexandrovna Piper, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10150 Centennial Pkwy, Ste. 230, Sandy, UT 84070 Phone: 425-284-1545 | |
James B Yee, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 9660 South 1300 East, Alta View Hospital, Sandy, UT 84094 Phone: 801-501-2600 Fax: 801-733-5618 | |
David A Pearson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 10011 S Centennial Pkwy, Suite 220, Sandy, UT 84070 Phone: 801-566-5350 Fax: 801-890-0706 |